10-Q: Terra Innovatum Global Goes Public, Reports Q3 Losses

Terra Innovatum Global N.V. completed its business combination and Nasdaq listing in October 2025, despite reporting significant net losses and negative operating cash flow for the nine months ended September 30, 2025.

Summary

• The business combination with GSR III Acquisition Corp. was completed on October 9, 2025, with ordinary shares commencing trading on Nasdaq under the ticker symbol NKLR on October 10, 2025.
• A net loss of $2,987 thousand was reported for the three months ended September 30, 2025, compared to net income of $16 thousand for the same period in 2024.
• A net loss of $5,580 thousand was reported for the nine months ended September 30, 2025, compared to net income of $36 thousand for the same period in 2024.
• Cash used in operating activities amounted to $3,688 thousand for the nine months ended September 30, 2025.
• The accumulated deficit stood at $5,617 thousand as of September 30, 2025.
• Bridge Loans totaling $5,690 thousand were converted into 851,483 ordinary shares at $7.00 per share and associated warrants upon the merger closing.
• PIPE proceeds of $36,790 thousand were received, involving the issuance of 3,683,500 PIPE shares and associated warrants.
• The company is developing the SOLO Micro-Modular Nuclear Reactor (SOLO), targeting commercial deployment by 2028.
• Material weaknesses in internal control over financial reporting were identified, including inadequate segregation of duties and insufficient written policies and procedures.

Sentiment

Score: 7

Explanation: While the company reported significant losses and negative cash flow for the period, the successful completion of the SPAC merger and Nasdaq listing, along with the substantial capital infusion, significantly de-risks the company's immediate financial viability and provides a platform for future development. The identified internal control weaknesses are a concern but are acknowledged and being addressed. The long-term nature of nuclear energy development means current losses are expected.

Positives

• Successfully completed the business combination and public listing on Nasdaq (NKLR), providing a platform for growth and access to capital markets.
• Significant additional liquidity was provided by the merger, including $36,790 thousand in PIPE proceeds and the conversion of bridge loans, addressing prior going concern doubts.
• Management believes existing cash will be sufficient to meet working capital and capital expenditure requirements for at least the next 12 months.
• Substantial progress has been made in de-risking the First-of-a-Kind (FOAK) reactor, including initiating regulatory engagement with the U.S. Nuclear Regulatory Commission (NRC) and establishing a robust supply chain strategy.
• The reactor design has been completed, and key technological components have been validated.
• An MOU was signed with Rock City Admiral Parkway Development to host the FOAK reactor, with an amendment providing an additional potential site.
• The strategic roadmap targets commercial deployment of the SOLO reactor by 2028.
• The SOLO reactor is designed for multi-sector versatility, targeting diverse energy-intensive industries to mitigate market concentration risks.

Negatives

• Reported a net loss of $2,987 thousand for the three months ended September 30, 2025, a significant decline from net income of $16 thousand in the prior year period.
• Reported a net loss of $5,580 thousand for the nine months ended September 30, 2025, compared to net income of $36 thousand in the prior year period.
• Experienced negative operating cash flow of $3,688 thousand for the nine months ended September 30, 2025.
• An accumulated deficit of $5,617 thousand was recorded as of September 30, 2025.
• Historically incurred recurring losses and negative operating cash flows.
• Identified material weaknesses in disclosure controls and procedures, specifically inadequate segregation of duties and insufficient written policies for accounting, IT, and financial reporting.
• General and administrative expenses increased significantly by $2,133 thousand for the three months and $5,648 thousand for the nine months ended September 30, 2025, primarily due to merger-related fees and public company operating costs.
• Development costs increased by $139 thousand for the three months and $191 thousand for the nine months ended September 30, 2025.
• Incurred significant interest expense of $537 thousand for the three months and $726 thousand for the nine months ended September 30, 2025, attributable to Bridge Loans.

Risks

• Commercial deployment of advanced nuclear reactors is contingent on securing regulatory approvals for design, construction, and operation, and the NRC review process may take longer than anticipated.
• The outsourced manufacturing approach and international supply chain expose the company to global supply chain vulnerabilities, including geopolitical tensions, trade agreements, tariffs, and manufacturing disruptions.
• Assembly preparation in Europe for deployment in the U.S. introduces currency exchange risks and logistical challenges.
• Inflationary trends pose a risk to development trajectory due to escalating costs in specialized manufacturing, regulatory compliance, technical talent acquisition, and raw material procurement.
• Economic growth cycles, shifts in energy policy, and potential slowdowns in technological adoption could materially affect market positioning and revenue projections.
• Changes in nuclear energy policies and geopolitical tensions could significantly impact market access.
• Potential labor market shifts and competition for specialized nuclear engineering expertise could influence human resource strategy and technology development velocity.
• Macroeconomic uncertainties, including potential recessionary periods and fluctuations in investment trends, could affect funding capabilities and customer acquisition strategies.
• Limited financial resources and no assurance that sufficient funding will be available to fund operating expenses and business development.
• The company anticipates needing to raise additional capital to fund operations while implementing its business plan.
• No revenue has been generated from product sales to date, and no meaningful revenue is expected until commercial deployment of SOLO, anticipated not before 2028.
• Material weaknesses in internal control over financial reporting, including inadequate segregation of duties and insufficient written policies and procedures, could adversely affect the ability to record, process, summarize, and report financial information.

Future Outlook

Management expects general and administrative expenses to increase in absolute dollars in future periods due to operating as a public company. The company does not anticipate generating meaningful revenue from product sales until the commercial deployment of the SOLO Micro-Modular Nuclear Reactor, targeted not before 2028. While management believes existing cash will be sufficient for at least the next 12 months following the merger and increased liquidity, additional capital raises, including equity offerings, may be considered to support growth. The commercial rollout of nuclear reactors is subject to lengthy regulatory approval processes, which may take longer than anticipated. The company plans to outsource manufacturing initially to avoid heavy capital investments but expects to require co-investments with suppliers and contract manufacturers after scaling up production.

Management Comments

• "Management therefore believes that existing cash will be sufficient to meet the Company’s working capital and capital expenditure requirements for at least the next 12 months."
• "We continue to monitor its liquidity position and may consider additional financing arrangements, including equity offerings, to support its growth strategy as appropriate."
• "Although our team has significant prior experience working with the NRC, we cannot control NRC’s review process and review periods may take longer than anticipated."
• "We do not expect to generate any meaningful revenue unless and until we are able to complete development, regulatory licensing and entering into the effective commercialization phase of the SOLO Micro-Modular Nuclear Reactor which we do not anticipate occurring before 2028."
• "We will be outsourcing manufacturing. Consequently, we will not need to invest heavily in manufacturing facilities for the first 2 to 3 years while scaling up to 1,000 units per year. After that, Terra will most likely require co-investments with suppliers and contract manufacturers."
• "If additional funding was made available earlier, we would be in a position to upfront some of the working capital and capital expenses requirements associated with a faster ramp up of the production capacity."

Industry Context

The company operates in the nuclear energy technology sector, focusing on Micro-Modular Nuclear Reactors (SMRs), which are a critical component of the global energy transition towards decarbonization and reliable low-carbon baseload power. The SOLO reactor's design targets diverse markets, including industrial manufacturing, critical infrastructure, agricultural applications, energy storage, and desalination, aligning with the increasing demand for energy, particularly from data centers and AI infrastructure. The use of commercially available Low Enriched Uranium (LEU) aims to reduce regulatory and technological barriers, a common challenge in nuclear energy development. The company's outsourced manufacturing approach is a strategic choice to manage capital expenditure in a capital-intensive industry.

Management Changes

Corporate Governance

Related Party Transactions

• Received $0 in other income from engineering consulting services to related parties for the three and nine months ended September 30, 2025 (compared to $34 thousand and $96 thousand in 2024, respectively).
• Interest-free loan agreements with quotaholders: 2024 Loan Agreement for $216 thousand (fully provided by March 31, 2025, maturing December 31, 2040, with extensions to 2045) and 2025 Loan Agreement for $221 thousand (to be provided by April 10, 2025, maturing December 31, 2040). Quotaholders advanced a total of $325 thousand as of September 30, 2025 (vs. $107 thousand as of December 31, 2024).
• Lease agreement with Nine Nuclear and Industrial Engineering S.R.L. (related party) for office rooms, term 24 months from April 1, 2025, at $12 per annum plus immaterial monthly fee for utilities/cleaning. Paid $3 thousand (3 months) and $7 thousand (9 months) in rent.
• Engineering services agreement with Nine Nuclear and Industrial Engineering S.R.L. (related party) for SOLO project design, total value $215 thousand plus VAT, with initial payment of $131 thousand in September 2025.
• Engineering services agreement with FPoliSolutions LLC (related party) for SOLO Micro Modular Reactor development support for $90 thousand, completed September 2025.

Stakeholder Impact

• Shareholders: The successful SPAC merger and Nasdaq listing provide liquidity and a public trading platform. The capital raise strengthens the balance sheet. However, significant historical losses and the long development timeline for the SOLO reactor mean profitability is distant. Warrants issued to bridge loan lenders and PIPE investors could lead to dilution.
• Employees: The company's focus on technology development and regulatory compliance, along with its international human capital strategy, suggests continued demand for specialized nuclear engineering talent.
• Customers: The SOLO reactor aims to address critical challenges in clean energy production for diverse markets, offering a compact, safe, and economically compelling alternative. Commercial deployment is targeted for 2028.
• Suppliers/Creditors: Bridge loan lenders converted their debt to equity and warrants, resolving those liabilities. The company's outsourced manufacturing approach relies on specialized suppliers.
• Regulatory Authorities (NRC): Ongoing engagement with the U.S. NRC for regulatory approvals is critical for the commercial deployment of the SOLO reactor.

Next Steps

• Continue FOAK development, engineering, and licensing activities for the SOLO Micro-Modular Nuclear Reactor.
• Address material weaknesses in internal control over financial reporting, specifically inadequate segregation of duties and insufficient written policies.
• Monitor liquidity position and potentially consider additional financing arrangements, including equity offerings.
• Work towards commercial deployment of the SOLO reactor by 2028.
• Engage with the U.S. Nuclear Regulatory Commission (NRC) for regulatory approvals.
• Continue examining potential alternative sites for the FOAK reactor.
• Implement financial communications program and investor relations activities with Alliance Advisors, LLC.
• Receive capital markets advisory services from Canaccord Genuity LLC, The Benchmark Company, and Roth Capital Partners, LLC.
• Engage Outside The Box Capital Inc. for marketing and distribution services.
• Conduct a feasibility and industrialization study (Phase 1) for the SOLO reactor with ATB Riva Calzoni S.p.A.

Key Dates

Recommendation

The company has successfully completed a major strategic milestone by going public and securing significant capital, which addresses immediate liquidity concerns and provides a foundation for its ambitious nuclear reactor development. However, it remains a pre-revenue company with a long development timeline (commercial deployment targeted for 2028) and has identified internal control weaknesses. The nuclear energy sector is highly regulated and capital-intensive, carrying inherent risks. While the long-term potential of its SOLO reactor is compelling, the significant execution risk, distant profitability, and the need for further capital raises suggest a 'Hold' for investors who are already invested or considering a speculative position, acknowledging both the recent positive developments and the substantial challenges ahead.

Keywords

Nuclear energy technology, Micro-Modular Nuclear Reactor, SOLO reactor, SPAC merger, Nasdaq listing, Clean energy, Small modular reactors, Energy transition, Regulatory approval, SEC filing, Form 10-Q, Financial results, Corporate governance, Risk factors, Capital markets, PIPE financing